Category

Daily Briefs

Daily Brief Industrials: Beijing Originwater Technology Co,Ltd., Hanwha Aerospace, Daewon San Up, HNI Corp, Honeywell International, Citra Marga Nusaphala Persada, Moriya Corp, OKP Holdings, Venus Pipes & Tubes, IRB InvIT Fund and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: Final Expectations; US$1bn+ Combined One-Way Flows
  • Hanwha Aerospace: Best Ever Results in 3Q 2025
  • Korea Small Cap Gem #48: Daewon Sanup
  • HNI: 3Q25 EPS Upside; Workplace Leading Indicators Firming
  • Weekly Update (WDC, AAF, LBTYA, LEN)
  • Primer: Citra Marga Nusaphala Persada (CMNP IJ) – Nov 2025
  • Primer: Moriya Corp (1798 JP) – Nov 2025
  • Fundamentals Driving Recent SMID Institutional Flows
  • Primer: Venus Pipes & Tubes (VENUSPIP IN) – Nov 2025
  • Primer: IRB InvIT Fund (IRBINVIT IN) – Nov 2025


Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: Final Expectations; US$1bn+ Combined One-Way Flows

By Janaghan Jeyakumar, CFA

  • The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
  • The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
  • In this insight, we have presented our final expectations for ADDs and DELs for the upcoming December 2025 index rebal event. 11 ADDs, 11 DELs, $2.3bn to trade.

Hanwha Aerospace: Best Ever Results in 3Q 2025

By Douglas Kim

  • In 3Q25, Hanwha Aerospace reported sales of 6.5 trillion won (up 146.5% YoY and 1.6% lower than consensus) and operating profit of 856.4 billion won (up 79.5% YoY).
  • The company’s results in 3Q 2025 were its best ever in its history. The strong results were driven by its land defense business and its shipbuilding unit Hanwha Ocean.
  • Given the company’s excellent growth in sales and profits in the past several years as well as its strong order backlog, its valuationsremain attractive. 

Korea Small Cap Gem #48: Daewon Sanup

By Douglas Kim

  • Daewon Sanup’s net cash as percentage of market cap is 171%. This is one of the highest net cash/market cap ratios in the Korean stock market.
  • Daewon Sanup is one of the largest Korean automobile seat manufacturers. It is also one of the beneficiaries of the reduction in US auto tariffs to 15% (from 25% previously). 
  • The company is trading at dirt cheap valuations. It is trading at P/E of 2.3x and P/B of 0.4x based on LTM financials. 

HNI: 3Q25 EPS Upside; Workplace Leading Indicators Firming

By Water Tower Research

  • HNI reported 3Q25 ongoing EPS of $1.10 versus $1.03 in 3Q24, up 6.8%, which was ahead of our $1.06 estimate, which was also consensus
  • Sales grew 1.7% in the quarter to $683.8MM, slightly below our forecast for 2.2% growth and consensus of 2.5% growth.
  • Excluding the HNI India divesture, organic sales growth was 2.6% in the quarter.

Weekly Update (WDC, AAF, LBTYA, LEN)

By Richard Howe

  • This week we had a busy week of earnings (WDC, AAF, LBTYA), and it will continue next week.
  • Honeywell (HON)  spun off 100% of its Advanced Materials business, Solstice (SOLS), on October 30, 2025.
  • Solstice was added to the S&P 500 and performed well on its first day of trading before selling off on Friday.


Primer: Citra Marga Nusaphala Persada (CMNP IJ) – Nov 2025

By αSK

  • CMNP is an established toll road operator in Indonesia with a portfolio of concessions primarily located in strategic, high-traffic urban areas, positioning it to benefit from the country’s continued economic growth and urbanization.
  • The company is embarking on significant expansion projects, notably the Harbour Road II, which is expected to drive future revenue growth. However, these projects also entail considerable execution and financing risks.
  • Valuation appears attractive, with a low price-to-book ratio and a high Smartkarma value score. This is contrasted by a lack of dividend payments and potential corporate governance concerns related to concession extensions that are under investigation.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Moriya Corp (1798 JP) – Nov 2025

By αSK

  • Moriya Corp is a well-established general construction company based in Nagano, Japan, with operations primarily in civil engineering, building construction, and real estate. The company has demonstrated a strong growth trajectory, underscored by a robust increase in market capitalization and a solid financial performance in recent years.
  • The Japanese construction market provides a stable, albeit moderately growing, backdrop, supported by significant government investment in infrastructure, disaster resilience, and renewable energy projects. Moriya is well-positioned to capitalize on these trends, particularly in public works and infrastructure renewal.
  • Despite a strong performance and an attractive valuation with a low P/E ratio, the company faces industry-wide challenges, including a shrinking workforce, rising material costs, and intense competition. Volatility in operating cash flow presents a key area for investor monitoring.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Fundamentals Driving Recent SMID Institutional Flows

By Geoff Howie

  • SMID stocks in Singapore saw S$472 million net institutional inflows in 2H25, reversing S$150 million outflows from 1H25.
  • Technology sector led SMID inflows with S$308 million, driven by AI adoption and CSE Global’s 50% share price increase.
  • Construction sector growth boosted nine SMID stocks, with OKP Holdings securing a S$258 million contract, increasing its order book.

Primer: Venus Pipes & Tubes (VENUSPIP IN) – Nov 2025

By αSK

  • Venus Pipes & Tubes is a rapidly growing manufacturer and exporter of stainless steel (SS) seamless and welded pipes and tubes in India, capitalizing on the expanding domestic and international demand across various industries.
  • The company is in the midst of a significant capacity expansion and backward integration strategy, which is expected to drive revenue growth, improve margins, and strengthen its market position.
  • While the company has demonstrated strong financial performance and a robust growth trajectory, it faces risks associated with the cyclicality of the steel industry, raw material price volatility, and increasing competition from both domestic and international players.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: IRB InvIT Fund (IRBINVIT IN) – Nov 2025

By αSK

  • Established Portfolio with Stable, Long-Term Cash Flows: IRB InvIT Fund owns a portfolio of operational toll road assets with long concession periods granted by the National Highways Authority of India (NHAI), providing predictable, long-term revenue streams essential for stable distributions to unitholders.
  • Strong Growth Trajectory via Strategic Acquisitions: The Trust is actively expanding its asset base through strategic acquisitions from its sponsor, IRB Infrastructure Developers Ltd. A recent major acquisition of three high-revenue BOT assets is set to double the enterprise value to over ₹16,000 crore and extend the weighted average life of the portfolio to 17 years.
  • Attractive Dividend Yield and Valuation: As an Infrastructure Investment Trust (InvIT), it is mandated to distribute 90% of its net distributable cash flow, resulting in a consistently high dividend yield. The units trade at an attractive price-to-book ratio, suggesting a favorable valuation relative to its underlying asset value.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Nintendo, Amazon, Mediatek Inc, Northsand, Confluent, Amkor Technology, Paypal Holdings, Seagate Technology Holdings PL, SUTL Enterprise, Corning Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Nintendo (7974) | Early Signals from the Switch 2 Cycle
  • Hyperscalers’ Cloud Revenue and Capex Update
  • Mediatek 3Q25: Good News (ASIC Revenue) But Weak Margins Getting Weaker. Stock Not Attractive.
  • Northsand Pre-IPO: Strong Topline Momentum With Improving Margins
  • Confluent: Real-Time Data Processing with Stream Processing & Flink Are Driving Growth!
  • Amkor Technology Doubles Down on Ultra-High-Density Packaging – Is This the Next Tech Revolution?
  • PayPal’s BNPL Boom: How Is It Winning Over Gen Z Shoppers?
  • Seagate Technology Goes All-In on HAMR – Will 40TB Drives Change Everything?
  • SUTL Enterprise Limited – Setting Sail for Regional Expansion
  • Corning Unveils What’s Next in Solar, Optical, and Auto Tech – Investors Take Note!


Nintendo (7974) | Early Signals from the Switch 2 Cycle

By Mark Chadwick

  • Switch 2 production signals confidence: Supplier orders for up to 25 mn units imply upside to Nintendo’s conservative guidance and likely operating profit revisions over FY3/26.  
  • Quarterly Earnings Sensitivity: Every 1 mn hardware units adds ¥11 bn to OP and 1 mn software units ¥3 bn, making Q2 results a key sentiment catalyst.
  • Sector positioning remains strong: With major global peers acquired, Nintendo stands as the premier pure-play gaming franchise; valuation premium sustained by scarcity and structural growth exposure.

Hyperscalers’ Cloud Revenue and Capex Update

By Nicolas Baratte

  • Hyperscalers (AMZN, GOOG, META, MSFT) revenues accelerating from 1Q25. Total revenues in 2025 ~$1.15tn, up 17% YoY.
  • Cloud (AWS, GOOG, MSFT) revenues accelerating. 2025 Cloud revenues in 2025 ~$375bn, up 25% YoY.
  • 2025 Capex up 63% YoY to $376bn. 2026 Capex will increase by ~46% YoY to reach ~$550bn. I estimate ~30% increase in 2027 to reach $715bn.

Mediatek 3Q25: Good News (ASIC Revenue) But Weak Margins Getting Weaker. Stock Not Attractive.

By Nicolas Baratte

  • Weak 3Q reported, weak 4Q guidance (Operating Margin) due to wafer price, some TSMC tightness (5-3nm), Opex increase. This should continue into 2026. Consensus too high. That should be negative.
  • But Management provides a very upbeat ASIC guidance: $1bn revenue in ’26, several bn in ‘27 , OP margin accretive at some point. Short-term pain, long-term gain.
  • MTK posits itself as the next ASIC disruptor, has several codesigns with Nvidia. But that’s material in ’27. The stock is down -8% YTD. Underperformance continues at least in 1H26.

Northsand Pre-IPO: Strong Topline Momentum With Improving Margins

By Hong Jie Seow

  • Northsand (446A JP) aims to raise around US$121m in its Japan IPO.
  • Northsand is a consulting firm that provides both IT and business consulting services. Established in 2015, it helps organizations improve efficiency, modernize operations, and achieve sustainable growth.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Confluent: Real-Time Data Processing with Stream Processing & Flink Are Driving Growth!

By Baptista Research

  • Confluent, a company specializing in data streaming solutions, reported solid quarterly results, surpassing all guided metrics.
  • The company’s subscription revenue saw a 19% increase year-over-year, reaching $286 million, while Confluent Cloud revenue increased by 24% to $161 million.
  • This highlights the firm’s strong growth trajectory in cloud services, which now represent 56% of its subscription revenue.

Amkor Technology Doubles Down on Ultra-High-Density Packaging – Is This the Next Tech Revolution?

By Baptista Research

  • Amkor Technology’s third-quarter 2025 financial results showcased strong performance and strategic advancements, yet they also highlighted some areas of pressure and challenges.
  • The company reported a revenue of $1.99 billion, marking a 31% sequential increase and a 7% year-over-year growth, exceeding expectations.
  • Earnings per share (EPS) for the quarter stood at $0.51, also above the guidance provided.

PayPal’s BNPL Boom: How Is It Winning Over Gen Z Shoppers?

By Baptista Research

  • PayPal’s third-quarter 2025 financial performance and strategic direction reveal a nuanced picture with both notable achievements and ongoing challenges.
  • The company has demonstrated impressive progress in strengthening its foundational operations and focusing on profitable growth.
  • Revenue has accelerated recently, stemming from strategies centered on expanding branded experiences, buy now, pay later (BNPL) services, and increased Venmo monetization.

Seagate Technology Goes All-In on HAMR – Will 40TB Drives Change Everything?

By Baptista Research

  • Seagate Technology recently reported its fiscal first-quarter 2026 results, showcasing a strong start to the year marked by notable financial performance and strategic advancements.
  • Positively, Seagate reported a year-over-year revenue growth of 21%, reaching $2.63 billion.
  • Non-GAAP gross margin reached a new record for the company at 40.1%, with operating margins climbing to 29%.

SUTL Enterprise Limited – Setting Sail for Regional Expansion

By SAC Capital

  • SUTL Enterprise Limited (“SUTL”) is a Singapore based developer, operator, and consultant of integrated marinas and remain as the only marina focused business listed on the SGX.
  • Under its proprietary ONE°15 Marina brand, the Group operates its flagship club at Sentosa Cove, manages third-party marinas across Asia, and runs a luxury yacht charter fleet of over 50 vessels.
  • Its core revenue streams comprise marina club operations (berthing, hospitality, and F&B services), consultancy and management fees for marina developments, and luxury yacht charters.

Corning Unveils What’s Next in Solar, Optical, and Auto Tech – Investors Take Note!

By Baptista Research

  • Corning Inc. reported a robust third quarter for 2025, demonstrating strong financial performance and strategic advancements across its business segments.
  • However, there are both positive factors and challenges that potential investors might want to consider when evaluating their investment in Corning.
  • Positively, Corning posted a year-over-year sales growth of 14% to $4.27 billion and an impressive 24% increase in earnings per share (EPS) to $0.67, with the operating margin expanding by 130 basis points to 19.6%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Beta Bionics, Biomarin Pharmaceutical, Hanmi Pharm, Novartis , Nurexone Biologic, Radiopharm Theranostics, Regeneron Pharmaceuticals and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Beta Bionics Inc. (BBNX.US): Solid 3Q’25 Results But Valuation Full at Current Levels
  • BioMarin Pharmaceutical Unleashes VOXZOGO Expansion—Is a Market Breakout Coming?
  • Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress
  • Novartis Supercharges Pluvicto—The Blockbuster Cancer Drug Investors Can’t Ignore!
  • NurExone Biologic’s Revolutionary Approach to Nerve Repair – 31 October 2025
  • RADX: Program and Financial Updates
  • Regeneron Bets Big on U.S. Manufacturing – Can $7 Billion Transform Its Future?


Beta Bionics Inc. (BBNX.US): Solid 3Q’25 Results But Valuation Full at Current Levels

By Andrei Zakharov

  • Beta Bionics Inc. has successfully completed its upsized US IPO in January and sold 13.8M shares at $17.00 per share, above the marketed price range.
  • Maker of the first FDA-cleared insulin delivery device reported better than expected 3Q’25 results, including revenue of $27.3M and an adjusted EBITDA loss of ~$12M.
  • While there is long term potential from interesting pipeline, I believe that the valuation is full, and I would wait a share pull-back before becoming more positive on the stock.

BioMarin Pharmaceutical Unleashes VOXZOGO Expansion—Is a Market Breakout Coming?

By Baptista Research

  • BioMarin Pharmaceutical Inc.’s latest earnings call reveals a complex mix of achievements and challenges, highlighting both substantial growth and notable strategic shifts.
  • Over the third quarter of 2025, BioMarin demonstrated robust financial performance, leading to an adjusted full-year revenue guidance.
  • The company reported an 11% increase in top-line revenue year-to-date, driven by the success of its global enzyme therapies and skeletal conditions business units, especially through the performance of VOXZOGO, its treatment for achondroplasia.

Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress

By Tina Banerjee

  • Hanmi Pharm (128940 KS) has reported mixed performance for 3Q25. Despite flat topline and high R&D investment, mid-single digit growth in operating profit is the key highlight of 3Q25 result.
  • Interim topline results of Phase 3 trials for efpeglenatide have raised expectations that the drug will establish itself as a “national obesity drug” based on excellent efficacy and proven safety.
  • The company submitted clinical trial application to FDA for HM17321. Hanmi received FDA approval to initiate a Phase 2 clinical trial with HM15275, which is expected to commence this month.

Novartis Supercharges Pluvicto—The Blockbuster Cancer Drug Investors Can’t Ignore!

By Baptista Research

  • Novartis recently announced its third-quarter 2025 financial results, highlighting a period of strategic growth and progress across multiple fronts.
  • The company registered a 7% increase in net sales, alongside a mirrored 7% uplift in core operating income, maintaining its core margin at 39.3%.
  • The results underscore Novartis’ ability to drive growth amidst challenges such as the loss of exclusivity (LOE) for key products like Entresto, Tasigna, and Promacta.

NurExone Biologic’s Revolutionary Approach to Nerve Repair – 31 October 2025

By Water Tower Research

  • NurExone is a biopharma company focused on developing regenerative exosome-based therapies for central nervous system injuries. 
  • Its lead development candidate, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury, both multi-billion-dollar markets.
  • Introducing Dr. Lior Shaltiel and Yoram Drucker. 

RADX: Program and Financial Updates

By Zacks Small Cap Research

  • Radiopharm Theranostics is advancing a portfolio of imaging and therapeutic radiopharmaceutical candidates in oncology.
  • Its approach recognizes the opportunities in tumors beyond prostate, thyroid & neuroendocrine targets originated by precision oncology & validated by clinical trials & regulatory approval.
  • RAD101, an 18F radioisotope developed to image brain metastases is the most advanced asset.

Regeneron Bets Big on U.S. Manufacturing – Can $7 Billion Transform Its Future?

By Baptista Research

  • Regeneron Pharmaceuticals reported its third-quarter 2025 financial results, showcasing a mixed performance with both strong growth in some product lines and challenges in others.
  • The company’s revenues reached $3.8 billion, marking a modest 1% increase from the previous year.
  • This growth was primarily driven by solid performances from several key products, including Dupixent, Libtayo, and EYLEA HD.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Light & Wonder , Hyundai Autoever , ANE Cayman Inc, Juroku Financial Group, Pine Labs, Samsung Electronics, Yum China Holdings , Beijing Originwater Technology Co,Ltd., CNOOC Ltd, Asian Paints and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Light & Wonder (LNW AU): Index Implications of NASDAQ Delisting & ASX Primary Listing
  • KOSPI200 Index Rebalance Preview: 7 Changes a Side for December
  • Merger Arb Mondays (03 Nov) – ANE, Dongfeng, Mayne, AUB, Digital Holdings, Makino, Soft99, SCSK
  • Japan 2025 H1 Bank Guidance/Results – Strong Upward Revisions Like Last Year – Likely More To Come
  • Pine Labs IPO: Slashed Offering Size & Lower Valuation
  • ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare
  • HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away
  • Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: Final Expectations; US$1bn+ Combined One-Way Flows
  • A/H Premium Tracker (Week to 31 Oct 2025):  Beautiful Skew Behaving Badly But RMB Counters Approach
  • India: Potential Free Float Changes & Passive Flows in November


Light & Wonder (LNW AU): Index Implications of NASDAQ Delisting & ASX Primary Listing

By Brian Freitas


KOSPI200 Index Rebalance Preview: 7 Changes a Side for December

By Brian Freitas



Japan 2025 H1 Bank Guidance/Results – Strong Upward Revisions Like Last Year – Likely More To Come

By Travis Lundy

  • In the days approaching H1 results in 2024, Japanese banks raised H1 guidance. Among the top 50 banks outside the top 10, the increase was significant. 
  • This year, out of those 50 banks, 12 have either reported (2) or raised guidance (10) for H1 in the past five weeks by an average of 47% (median 43%). 
  • Higher loan income, core business profits, and lower credit costs are the main culprits. Expect lots more guidance revisions in the next 10 days.

Pine Labs IPO: Slashed Offering Size & Lower Valuation

By Brian Freitas

  • Pine Labs (0568874D IN) is looking to list on the exchanges by selling 176.5m shares via a primary and secondary offering to raise US$439m at a valuation of US$2.86bn.
  • The price band has been set at INR 210-221/share and could price at the top end of the range. The IPO raise and valuation are sharply lower than earlier reports.
  • Inclusion at regular rebalances will commence in May but flow will be small given the low float and the Smallcap indices that it is added to.

ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, there were a flurry of deal launches across Hong Kong and India.
  • On the placements front, while the week was rather quiet, we did have a look at the upcoming lockup release.

HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away

By Brian Freitas

  • There could be 3 changes for the Hang Seng China Enterprises Index (HSCEI INDEX) in December. Announcement is on 21 November with implementation at the close on 5 December.
  • The forecast adds have moved higher over the last few months and handily outperformed the forecast deletes and the Hang Seng China Enterprises Index (HSCEI INDEX)
  • There has been aggressive short covering in the forecast adds and there could be more in stocks where short interest is still a high percentage of float.

Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: Final Expectations; US$1bn+ Combined One-Way Flows

By Janaghan Jeyakumar, CFA

  • The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
  • The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
  • In this insight, we have presented our final expectations for ADDs and DELs for the upcoming December 2025 index rebal event. 11 ADDs, 11 DELs, $2.3bn to trade.

A/H Premium Tracker (Week to 31 Oct 2025):  Beautiful Skew Behaving Badly But RMB Counters Approach

By Travis Lundy

  • Big Beautiful Skew was again a no-show. But the SFC’s expectation of dual counter eligibility for Connect by year-end approaches its endgame.
  • The GAC (2238 HK) reco 2wks ago worked well. One extra week was bad. Last week’s reco on CNOOC Ltd (883 HK) was a disaster. H underperformed A by 8.4%.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

India: Potential Free Float Changes & Passive Flows in November

By Brian Freitas

  • Companies in India have disclosed their shareholding pattern as of end-September in October. There are companies with significant float changes from end-June and/or end-March.
  • The changes in free float could be reflected in domestic and global indices over the next few weeks and months resulting in flow from passive trackers.
  • Depending on the date that the shareholding was published, there could be 20 stocks with passive inflows from global trackers while 6 could have passive outflows in November.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Consumer: Yum China Holdings , Robotis, Pop Mart, Sheng Siong, Booking Holdings, 1 800 flowers.com inc cl a, DigiPlus Interactive , Kia Corp, MGM China Holdings, Mondelez International and more

By | Consumer, Daily Briefs

In today’s briefing:

  • HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away
  • KOSDAQ150 Index Rebalance Preview: Large Number of Changes Likely in December; Huge Outperformance
  • Pop Mart (9992 HK) 25Q3 – The Decline in Stock Prices May Not Have Ended Yet
  • Sheng Siong (SSG SP): Surpassing Expectations Handsomely, But Fairly Valued. Money Off The Table?
  • Booking Holdings Just Launched a B2B Shakeup—Here’s What It Means for Travel Giants!
  • FLWS: 1QFY26 Sales and EPS Below Expectations; Reducing Estimates
  • Shortlist of High Conviction Philippines Equity Ideas – November 2025
  • Long Kia (000270 KS) Vs. Short Hyundai (005380 KS): Quant Model Hits Trigger Zone in Korean Autos
  • Lucror Analytics – Morning Views Asia
  • Mondelez International: Inside the Cocoa Crisis—And the Strategy That Could Beat It!


HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away

By Brian Freitas

  • There could be 3 changes for the Hang Seng China Enterprises Index (HSCEI INDEX) in December. Announcement is on 21 November with implementation at the close on 5 December.
  • The forecast adds have moved higher over the last few months and handily outperformed the forecast deletes and the Hang Seng China Enterprises Index (HSCEI INDEX)
  • There has been aggressive short covering in the forecast adds and there could be more in stocks where short interest is still a high percentage of float.

KOSDAQ150 Index Rebalance Preview: Large Number of Changes Likely in December; Huge Outperformance

By Brian Freitas

  • With the review period for the December rebalance complete, we highlight 17 potential changes for the KOSDAQ 150 Index (KOSDQ150 INDEX)
  • The estimated impact on the potential inclusions ranges from 0.1-3.2 days of ADV while the impact on the potential deletions varies from 0.7-11.2 days of ADV.
  • The forecast adds have outperformed the forecast deletes over the last 6 months with a big move higher in the last couple of months. Trim positions into strength.

Pop Mart (9992 HK) 25Q3 – The Decline in Stock Prices May Not Have Ended Yet

By Xinyao (Criss) Wang

  • Pop Mart’s 25Q3 results beat expectations, mainly driven by high growth of revenue attributed from operations overseas. The “online + offline + overseas” three-wheel drive strategy has achieved remarkable performance.
  • However, the market has expressed concerns over the IP life cycle and performance sustainability of Pop Mart through the decline in its stock price, which may not have ended yet.
  • There are no signs that new products can catch up with LABUBU. Once market sentiment reverses, it will affect Pop Mart’s valuation outlook. 30-35x P/E is a more comfortable range.

Sheng Siong (SSG SP): Surpassing Expectations Handsomely, But Fairly Valued. Money Off The Table?

By Sameer Taneja

  • Sheng Siong (SSG SP) surpassed expectations in Q3 2025, delivering revenue/profit growth of 14%/12% YoY, with FY25e store expansions totaling 11 stores, bringing the total to 86 in Singapore. 
  • The company is now pursuing a strategy of mall openings in tandem with its already successful HDB strategy, resulting in a higher growth rate than previously expected. 
  • Despite the more rapidly expanding footprint in Singapore, we believe the company is now fairly valued at 24.4x FY25PE with risks from the Johor Bahru-Singapore RTS and the associated SEZ. 

Booking Holdings Just Launched a B2B Shakeup—Here’s What It Means for Travel Giants!

By Baptista Research

  • Booking Holdings delivered a strong performance in the third quarter, demonstrating resilience and adaptability in a dynamic travel industry landscape.
  • The company’s broad global footprint and diversified revenue streams contributed to robust financial results that surpassed expectations.
  • These results were highlighted by several key metrics that combined both positive trends and potential areas of caution.

FLWS: 1QFY26 Sales and EPS Below Expectations; Reducing Estimates

By Water Tower Research

  • FLWS reported 1QFY26 adjusted EPS of ($0.83) versus ($0.51) in 1QFY25, and below our ($0.50) estimate and FactSet consensus of ($0.59).
  • Sales in the quarter decreased 11.1% to $215.2MM, below our $219.6MM estimate and consensus of $218.4MM.
  • However, management indicated that $3-4MM of wholesale sales that were shipped in the September quarter a year ago shifted to the December quarter this year, so excluding that shift, sales were about as expected. 

Shortlist of High Conviction Philippines Equity Ideas – November 2025

By Sameer Taneja

  • We are gradually building a high-conviction coverage of ideas for mid and small-cap companies in the Philippines.
  • We established metrics focused on high ROCE, sustainable 10-15% YoY growth, robust balance sheets, and prudent capital allocation —essential elements for identifying potential multi-bagger opportunities.
  • Our focus turns to the Q3 FY25 earnings season, where we provide brief previews on the names we cover as they report earnings over the course of the month. 

Long Kia (000270 KS) Vs. Short Hyundai (005380 KS): Quant Model Hits Trigger Zone in Korean Autos

By Gaudenz Schneider

  • Context: The Kia (000270 KS) vs. Hyundai (005380 KS) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Kia (000270 KS) and short Hyundai (005380 KS) targets a 12% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • Front-end UST yields declined on Friday, unwinding part of the jump in yields following the FOMC rate decision on Wednesday.
  • The yield on the 2Y UST fell 4 bps to 3.57%, while the yield on the 10Y UST was down 2 bps at 4.08%. Equities climbed, supported by optimism over corporate earnings.
  • The S&P 500 gained 0.3% to 6,840, while the Nasdaq rose 0.6% to 23,725. 

Mondelez International: Inside the Cocoa Crisis—And the Strategy That Could Beat It!

By Baptista Research

  • Mondelez International’s third-quarter earnings call presented a mixed bag of outcomes, reflecting both challenges and strategic moves aimed at navigating the current economic landscape.
  • The company highlighted key areas of focus and concern in its performance across different regions, particularly in Europe and North America, with implications affecting both short-term operations and long-term strategy.
  • In Europe, Mondelez experienced stable consumer confidence, yet faced significant challenges in its chocolate segment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Elite UK REIT, FnGuide Inc, Nikkei 225, Exzeo Group, Groupe Bruxelles Lambert Sa, Valuetronics Holdings, Central Bancompany and more

By | Daily Briefs, Financials

In today’s briefing:

  • Elite UK REIT: October 2025 Update
  • Total Net Asset Value of ETFs Based on FnGuide Indices Exceeds 30 Trillion Won (US$21 Billion)
  • Cross-Market Outlook: US Vs Asia — Who’s Overbought, Who’s Oversold?(Nov 4, 2025)
  • Exzeo Group, Inc. (XZO): Profitable HCI Spinoff Insurtech Drawing Interest from IPO Investors
  • 2025 Buyback Consideration Surpasses 10-year High
  • Selected European HoldCos and DLC: October 2025 Report
  • 2025 Buyback Consideration Surpasses 10-year High
  • Central Bancompany, Inc. (CBC):Missouri Based Bank Sets Terms, Seeking $5.0b+ Valuation


Elite UK REIT: October 2025 Update

By Wealth Management Alliance

  • This report provides an update of Elite UK REIT (SGX: MXNU), after our initiation report dated 18 March 25.
  • Then, we had a price target of GBP0.30. We have increased the target price now to GBP0.39 in view of the REIT’s pivot and diversification and factoring in the market’s willingness to accept a smaller traded discount on the REIT’s share to its NAV.
  • Since our initiation report, several positive developments have emerged.

Total Net Asset Value of ETFs Based on FnGuide Indices Exceeds 30 Trillion Won (US$21 Billion)

By Douglas Kim

  • FnGuide is one of the key beneficiaries of the increased index investing in Korea. 
  • Total net assets of ETFs tracking FnGuide indices surged from about 14 trillion won at the end of 2024 to about 30 trillion won as of end of October 2025.
  • There has been a sharp increase in foreign ownership of FnGuide from 0.4% at the end of 2023 to 14.5% as of 3 November 2025.

Cross-Market Outlook: US Vs Asia — Who’s Overbought, Who’s Oversold?(Nov 4, 2025)

By Nico Rosti

  • A look at our probabilistic tactical models for US and Asian Equities: comparing which stocks are overbought and which ones are oversold.
  • Most of the U.S. and Asian stocks we track are overbought, with Asian markets showing the strongest overbought conditions. 
  • Meta (META US)  and the CSI 300 Index (SHSZ300)  offer bargain-hunting opportunities for tactical investors.

Exzeo Group, Inc. (XZO): Profitable HCI Spinoff Insurtech Drawing Interest from IPO Investors

By IPO Boutique

  • Exzeo Group (XZO US), a profitable spin-off from HCI Group, enters the market with exceptional financial discipline under CEO Paresh Patel.
  • With $195 million in annual recurring revenue, 51.6% EBITDA margins, zero debt, and $75 million in free cash flow, Exzeo stands out as a combination of scale and profitability.
  • Books are well oversubscribed heading into pricing, with a Thursday debut anticipated. However, Truist Securities’ role as lead left underwriter introduces some execution uncertainty given its limited IPO track record.

2025 Buyback Consideration Surpasses 10-year High

By Geoff Howie

  • In 2025, 78 primary-listed Singapore companies repurchased S$1.91 billion in shares, a 90% increase from 2024.
  • 17Live Group repurchased S$6.2 million shares, 3.4% of its market capitalisation, reflecting disciplined capital deployment.
  • Jason Marine Group’s first buyback since 2015 followed a 40% revenue increase and strong project deliveries.

Selected European HoldCos and DLC: October 2025 Report

By Jesus Rodriguez Aguilar

  • GBL: discount 28.6% (Oct 31). Selling €1.7bn GBL Capital NAV for €1.5bn cash (+€0.4bn deferred); €0.6bn commitments transferred. Simpler, more liquid, greater buyback firepower—supports discount narrowing.
  • Sweden: Industrivärden discount 5.8% (near lows). Investor AB resilient; NAV SEK 1,024bn, TSR +5%. Quality ballast, limited discount alpha now.
  • Vivendi: 33.2% discount to €4.67 NAV; AMF-driven OPA path intact. Scenario-weighted value ~€4.17; prefer outright long or stub vs UMG/Banijay/MFE; trim if discount narrows to 10–15%.

2025 Buyback Consideration Surpasses 10-year High

By Geoff Howie

  • In 2025, 78 primary-listed Singapore companies repurchased S$1.91 billion in shares, a 90% increase from 2024.
  • 17Live Group repurchased S$6.2 million shares, 3.4% of its market capitalisation, reflecting disciplined capital deployment.
  • Jason Marine Group’s first buyback since 2015 followed a 40% revenue increase and strong project deliveries.

Central Bancompany, Inc. (CBC):Missouri Based Bank Sets Terms, Seeking $5.0b+ Valuation

By IPO Boutique

  • Central Bancompany (CBC) targets a late-November IPO with strong fundamentals—$19.1B in assets, $14.2B in wealth under advice, and consistent profitability across diversified Midwest banking operations.
  • The $5B–$5.7B Missouri-based bank’s offering seeks $374M in proceeds to support expansion and potential acquisitions, highlighting disciplined growth and a proven 123-year legacy of stability.
  • Despite the ongoing government shutdown, CBC’s IPO remains on track for November 21, marking one of the largest and most diversified bank debuts in 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: KRX Foreign Holding Weekly (Oct 31st): SK Hynix and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • KRX Foreign Holding Weekly (Oct 31st): SK Hynix, Samsung Electronics, Hanwha Ocean, Hyundai Motor
  • TWSE Foreign Holding Weekly (Oct 31st): TSMC, Delta Electronics, ASE Industrial, E.SUN Financial
  • HK Connect Flows Weekly (Oct 31st): CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent
  • HK Short Interest Weekly: Shandong Gold Mining, CSPC Pharma, CCB, Zhaojin Mining Industry
  • A-H Premium Weekly (Oct 31st): Sinotrans, Jiangxi Copper, Everbright Securities
  • TWSE Short Interest Weekly (Oct 31st): Lite-On Technology, Yageo, TECO Electric & Machinery
  • Bursa Short Interest Weekly (Oct 31st): Inari Amertron, Ekovest, Mah Sing, Cahya Mata Sarawak
  • CSI 100 Index Earning Revision (Oct): GANFENG LITHIUM, CHONGQING ZHIFEI BIOLOGICAL PRODUCTS
  • Thailand Short Interest Weekly (Oct 31st): Intouch, PTT, Kasikornbank, Advanced Info Service, CP ALL


KRX Foreign Holding Weekly (Oct 31st): SK Hynix, Samsung Electronics, Hanwha Ocean, Hyundai Motor

By Ke Yan, CFA, FRM

  • We analyzed the changes in foreign holdings of KRX stocks as of Oct 31st. The aggregated holding was USD862.4bn.
  • We estimate that foreign flows to be inflows of USD77mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
  • We highlight changes of foreign holdings in SK Hynix, Samsung Electronics, Hanwha Ocean, Hyundai Motor, Samsung Elec (PREF).

TWSE Foreign Holding Weekly (Oct 31st): TSMC, Delta Electronics, ASE Industrial, E.SUN Financial

By Ke Yan, CFA, FRM

  • We analyzed the changes in foreign holdings of TWSE Stocks as of Oct 31st. The aggregated holding was USD1,429.4bn.
  • We estimate that foreign flows to be outflows of USD1,180mln. We tabulate the league tables for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
  • We highlight changes of foreign holdings in TSMC, Delta Electronics, ASE Industrial, E.SUN Financial, Quanta Computer, Ase Industrial, Quanta Computer, TSMC, Delta Electronics, E.Sun Financial.

HK Connect Flows Weekly (Oct 31st): CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent

By Ke Yan, CFA, FRM

  • We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of October 31st.
  • The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
  • We highlight flows for CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent, Meituan, Li Auto.

HK Short Interest Weekly: Shandong Gold Mining, CSPC Pharma, CCB, Zhaojin Mining Industry

By Ke Yan, CFA, FRM

  • We analyzed the latest HK SFC report for aggregate short position as of Oct 24th.
  • Top short increases and decreases were tabulated for one week and four week period.
  • We highlight short changes in Shandong Gold Mining, CSPC Pharma, CCB, Zhaojin Mining Industry.

A-H Premium Weekly (Oct 31st): Sinotrans, Jiangxi Copper, Everbright Securities

By Ke Yan, CFA, FRM

  • We analyse the changes of A-H premium on 157 stocks over the last week. The average A-H premium was 62.2% as of Oct 31st.
  • The average A-H premium changed by 2.3ppt week-on-week, led by consumer discretionary, information technology, financials and offset by real estate.
  • We highlight weekly changes in A-H premium for Sinotrans, Jiangxi Copper, Everbright Securities, Guangzhou Automobile.

TWSE Short Interest Weekly (Oct 31st): Lite-On Technology, Yageo, TECO Electric & Machinery

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of TWSE Stocks as of Oct 31st. The aggregated short interest was USD28.2bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Lite-On Technology, Yageo, TECO Electric & Machinery, WT Microelectronics, Nanya Technology, Lite-On Technology, Yageo, TECO Electric & Machinery, WT Microelectronics, Nanya Technology.

Bursa Short Interest Weekly (Oct 31st): Inari Amertron, Ekovest, Mah Sing, Cahya Mata Sarawak

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of Bursa stocks as of Oct 31st. The aggregated short interest is USD438m.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Inari Amertron, Ekovest, Mah Sing, Cahya Mata Sarawak, KPJ Healthcare.

CSI 100 Index Earning Revision (Oct): GANFENG LITHIUM, CHONGQING ZHIFEI BIOLOGICAL PRODUCTS

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of CSI 100 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on GANFENG LITHIUM, CHONGQING ZHIFEI BIOLOGICAL PRODUCTS, PING AN INSURANCE, GREE ELECTRIC APPLIANCES, Moutai, CAMBRICON TECHNOLOGIES, BYD, CSSC, Ping An Insurance, BYD, Cssc, Moutai.

Thailand Short Interest Weekly (Oct 31st): Intouch, PTT, Kasikornbank, Advanced Info Service, CP ALL

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of Stock Exchange of Thailand as of Oct 31st. We estimate that they had an aggregated short interest worth USD2.4bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Intouch, PTT, Kasikornbank, Advanced Info Service, CP ALL, Kasikornbank, CP ALL, Ptt, Advanced Info Service.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Parent-Subsidiary Listing Focus: From Small-Scale Fixe to Real Reform and more

By | Daily Briefs, ESG

In today’s briefing:

  • Parent-Subsidiary Listing Focus: From Small-Scale Fixe to Real Reform, from Prime to Standard Market


Parent-Subsidiary Listing Focus: From Small-Scale Fixe to Real Reform, from Prime to Standard Market

By Aki Matsumoto

  • The number of listed subsidiaries is decreasing, while equity-method affiliates are increasing. If parent-subsidiary listings are dissolved by selling part of equity interests, this doesn’t lead to fundamental management reform.
  • While some companies have finally gotten off their backsides after seeing engagement results, the challenge is shifting to the many companies that refuse to seriously confront management reform.
  • Investors want confidence in which businesses generate and expand the company’s overall cash flow. A serious business portfolio restructuring to provide that confidence remains only halfway complete.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): China & HK Strategy: Stock Implications for 4Q25 and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • China & HK Strategy: Stock Implications for 4Q25
  • Ohayo Japan | Record Highs in Japan
  • Hardman & Co Monthly: November 2025


China & HK Strategy: Stock Implications for 4Q25

By Osbert Tang, CFA


Ohayo Japan | Record Highs in Japan

By Mark Chadwick

  • U.S. stocks closed higher, primarily driven by a significant rally in Amazon shares following strong quarterly results & cloud computing growth.
  • Nexperia: Wafer supply suspension by Dutch parent on Oct 26 due to payment terms dispute; China unit asserts sufficient inventories and stable supply chain
  • Japan closed on Monday for Culture Day Holiday; Tues Earnings: Nintendo, Mitsubishi, NTT, Marubeni & more

Hardman & Co Monthly: November 2025

By Hardman & Co

  • Feature article: Feeding the future The case for food system investment Megatrends, at a very basic level, dictate the “direction of travel” for economic, social and political activity; investments made on this basis will receive powerful trend support.
  • Today, the transformation of the global food system represents one such structural force.
  • As demographic expansion, rising income and growing climate pressure converge, food sustainability as a strategic, long-term investment theme is no longer a forward-looking concept but a current market reality.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: ECM Weekly (3 November 2025)-Sany and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare
  • Mininglamp Technology IPO Trading: Strong Retail Demand, Decent Insti Demand
  • Pre-IPO Softcare (PHIP Updates) – Some Points Worth the Attention


ECM Weekly (3 November 2025)-Sany, Seres, CIG, PonyAI, WeRide, Mininglamp, Lenskart, Groww, Softcare

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, there were a flurry of deal launches across Hong Kong and India.
  • On the placements front, while the week was rather quiet, we did have a look at the upcoming lockup release.

Mininglamp Technology IPO Trading: Strong Retail Demand, Decent Insti Demand

By Hong Jie Seow

  • Mininglamp Technology (1912140D HK) raised around US$131m in its Hong Kong IPO.
  • Mininglamp Technology (formerly known as Leading Smart Holdings), is a data intelligence software provider in China, specializing in transforming enterprises’ marketing and operational decision-making.
  • We have looked at the company’s background and pricing in our earlier note, in this note we talk about the trading dynamics.

Pre-IPO Softcare (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • The rise of Softcare is in line with the logic of “Chinese supply chain going global”.It has solved channel/cost problems through localized production, quickly captured market share with low-price tactic.
  • Our forecast benefiting from market penetration/capacity expansion, revenue growth could be 15% YoY in 2025.In 2026-2027, as competition intensifies, revenue growth may slow down to 12% YoY, 10% YoY respectively.
  • Given that Softcare’s main market is in Africa, which is characterized by high growth and high risk, a forecasted P/E of 8-12x for 2025 could be a comfortable valuation range.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars